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ABSTRACT Contrast in MRI relies on differences in the
local environment of water and is often enhanced by using
contrast agents. We present a simple model for evaluating the
minimal contrast agent concentration required to produce
‘‘satisfactory’’ contrast enhancement in magnetic resonance
images. Previous strategies have been based largely on em-
pirical results for specific systems. The present tissue contrast
model (TCM) can be applied to ‘‘conventional,’’ targeted, or
biochemically responsive agents. The model results are for-
mulated so that only a small number of parameters are
required to analyze a given scenario. The TCM is a particu-
larly useful tool in the development of new classes of magnetic
resonance contrast media. These agents will have the ability
to target specific cells or tissue, and perhaps be able to report
on their physiological status. As an example of the applica-
bility of the TCM, we test it against in vivo magnetic resonance
microscopy results in frog embryos that have focal cell
populations labeled with contrast agent by using calibrated
single-cell microinjection techniques.
One of the powers of magnetic resonance imaging (MRI) is its
ability to extract image contrast, or a difference in image
intensity between tissues, on the basis of variations in the local
environment of mobile water. Differences in the longitudinal
relaxation time, or T1, between tissues is a commonly exploited
contrast mechanism. T1 is the characteristic time constant for
a population of nuclear (proton) magnetic moments placed in
a magnetic field to equilibrate along the field direction.
Because intrinsic differences in T1 between tissues can be
small, a frequent method of contrast enhancement is through
the use of exogenous contrast media (1). These agents typically
consist of a lanthanide metal ion, usually Gd31, that is chelated
to a low molecular weight complex. Water molecules in
proximity to the complex experience a reduction in T1; con-
sequently, contrast enhancement can result from differences in
agent concentration. ‘‘Conventional’’ T1 contrast media, such
as gadolinium chelated by diethylenetriaminepentaacetic acid
(Gd-DTPA), are routinely used clinically to enhance lesions or
fluid compartments (1); such agents are used because they
have a nonselective extracellular distribution and are physio-
logically inert (2).
An emerging field of contrast enhancement, which is still in
its infancy, is the development and utilization of several
different classes of MRI contrast agents that are designed to
highlight specific tissues or organs. These classes can be
characterized as having targeted or functional properties.
Targeted agents exhibit a preferential increase in agent con-
centration in specific tissues. This increase can occur due to
selective uptake, selective clearance, or direct injection into
specific cells or tissues. Functional agents, on the other hand,
are designed to be chemically responsive to the physiological
state or function of cells or organs. These agents offer the
potential of reporting on the local physiological environment
by modification of their effectiveness in relaxing nuclear spins,
or relaxivity. Certain classes of agents can exhibit both tar-
geting and functional properties in vivo (3–5).
Applications of targeted and functional agents are beginning
to emerge. Microinjected contrast agents have allowed micro-
scopic magnetic resonance imaging (mMRI) to visualize cell
lineages and track neural development in vivo in developing
embryos (6). Other examples of targetedyfunctional agents
include lipophilic agents, which target the liver (4, 5, 7, 8);
macromolecular complexes, which function as blood pool
markers (9); lymphotropic agents (10); magnetoimmuno
agents, which target specific cell surface receptors (11, 12);
and, recently, manganese ions, which enter through calcium
channels of neurons, have been used to highlight regions of
brain activation (13).
In addition to agent concentration differences, in situ mod-
ification of the agent’s relaxivity by a number of mechanisms
can result in functional contrast enhancement. In complexes
such a Gd-DTPA, at high magnetic field strengths, the relax-
ivity can be modulated by altering the rotational degrees of
freedom [parameterized by the correlation time tR (14–16)].
Reduction of tR through reversible macromolecular binding,
for example, is effective in increasing relaxivity (3–5). Modu-
lating other degrees of freedom affecting relaxivity has also
been suggested, such as biochemically controlling water ex-
change to the inner coordination sphere of the chelate-bound
metal ion in response to enzymatic activity (17).
The development of novel contrast agents by any of these
schemes requires a rational strategy for predicting their effec-
tiveness in producing contrast enhancement. Previous strate-
gies have been based largely on empirical results for specific
systems (for example, see ref. 18). Toward this aim, we present
a simple theoretical framework for evaluating the minimal
agent concentration required to produce ‘‘satisfactory’’ con-
trast in magnetic resonance images. This tissue contrast model
(TCM) can be applied to conventional, targeted, or functional
contrast agents. The results of the TCM are a set of equations
that approximate the minimal agent concentration: (i) in a
targeted area when a finite concentration exists in both
regions, (ii) for a local microinjection into one of the regions,
and (iii) for a functional agent that is turned ‘‘on’’ in one of the
regions by some chemical process. We formulate the results so
that only a small number of experimentally accessible param-
eters are required to analyze a given scenario.
As an example of the applicability of the TCM, we discuss
in vivo mMRI results in Xenopus laevis (African clawed frog)
embryos that have focal cell populations labeled with gado-
linium 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-
1,4,7-triacetic acid (GdHP-DO3A; ProHance, Bracco Diag-
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nostics, Princeton, NJ) by using calibrated single-cell micro-
injection techniques. Through the application of the TCM to
this specific system, we demonstrate the predictive capabilities
of the model and show how the relevant system-specific
parameters can be evaluated.
Theory
We consider contrast between two homogeneous tissue re-
gions, labeled a and b. Both regions contain volumes much
larger than the voxel size. Intravoxel partial volume effects are
not considered. For example, the two regions might corre-
spond to a subset of cells labeled by microinjection within an
ensemble of otherwise identical cells. In the absence of any
agents, both tissues are assumed to have the same ‘‘back-
ground’’ longitudinal relaxation time, T01, and inherent proton
environment. The presence of the agent in regions a and b
results in T1a , T1b. In these regions, T1 is modulated by
changes in either the concentration or the relaxivity of the
agent. We assume that within a or b water is in ‘‘fast exchange’’
with the ligand and that the relaxation is described by a
monoexponential. Modifications to this model can be made on
a case-by-case basis if characteristics, such as T01, T2, or the
relative spin density, differ between regions a and b.
We consider two imaging pulse sequences: the spin-echo
(SE) sequence (90° 2 TEy2 2 180° 2 TEy2 2 acquisition 2 t),
and the inversion-recovery spin-echo (IR) sequence (180° 2 TI
2 90° 2 TEy2 2 180° 2 TEy2 2 acquisition 2 t). The total
sequence repetition time is given by TR 5 t 1 TE and TR 5 t
1 TI 1 TE for the SE and IR sequences, respectively. We
assume that selective pulse excitation profiles are rectangular,
and all pulses are short compared with the above times. For
real images, the signal per voxel is given by (19–23)
ISE
i 5 k~1 2 2e2~TR2TEy2!yT1i 1 e2TRyT1i!e2TEyT2 [1]
for the SE sequence and
IIR
i 5 k~1 2 2e2TIyT1i 1 2e2~TR2TEy2!/T1i 2 e2TRyT1i!e2TEyT2
[2]
for the IR sequence, where i 5 a, b index the two regions. Eqs.
1 and 2 assume that the transverse magnetization is completely
dephased before the onset of the next pulse cycle. The value
of k depends on many parameters that are specific for a given
imaging system, such as details of the radio frequency detec-
tion system (coil quality factor, filling factor, etc.). k scales
linearly with voxel volume, which is assumed to be equal for the
two regions, and is independent of both the interpulse delay
times and the relaxation times.
The contrast-to-noise ratio, b, between regions a and b for
real images is defined as the difference in the image signal-
to-noise ratios (IiyN) between the two regions, or
b 5
Ia 2 Ib
N
, [3]
where N is the statistical image noise and Ia . Ib.
Note that in the limits of TE3 0, and TR, TI3 `, Eqs. 1 and
2 reduce to Ii 5 k. The quantity kyN is an important parameter
in the model and can be interpreted as the upper limit to the
signal-to-noise ratio achievable for a given imaging system and
subject. The ratio kyN is independent of imaging protocol (SE
or IR) and can readily be estimated from acquired image data
(see Experiment).
The contrast-to-noise ratio between regions a and b is
experimentally controlled by choosing the parameters TE, TR,
and TI. Several authors analyze the choice of these parameters
to optimize the T1-weighted contrast-to-noise ratio (19–23).
We assume that T1-weighted images of regions a and b are
acquired by using optimal imaging parameters. When either
the SE or the IR sequence is used, TE should be set as short
as possible (often less than, or of order of, 10 ms) and is
typically limited by the finite sampling time and other instru-
mental limitations. TR and TI, normally used to adjust T1
contrast for SE and IR, yield optimal contrast when set to the
value T9 given by
T9 5
T1aT1b
T1b 2 T1a
lnST1bT1aD , [4]
where Eq. 4 assumes TE ,, TR, TI, T2, and a fixed number of
averages. In addition, for the IR sequence, one sets TR .. TI.
Eq. 4 is obtained by maximizing b with respect to TR or TI for
SE or IR, respectively, and has been previously reported [for
example, see Hendrick and co-workers (23)].
The ratio T1ayT1b can be expressed in terms a set of
transcendental equations that describe the amount that T1a
and T1b must differ to provide a contrast-to-noise ratio of b.
For SE, combining Eqs. 1 and 3, we obtain
T1a
T1b
5 2 fF lnS2 Nbk 1 e2fDG
21
. [5]
Similarly for IR, Eqs. 2 and 3 yield
T1a
T1b
5 2FF lnS2 Nb2k 1 e2FDG
21
. [6]
In Eqs. 5 and 6, f 5 TRyT1b and F 5 TIyT1b. Note that T1ayT1b
, 1. Our goal is to evaluate the minimal agent concentrations
in regions a and b that result in visible image differences. In the
following analysis, we will use the value b 5 5 as the lower limit
to the contrast-to-noise ratio that is visually obvious (see Fig.
1).
Next, we construct approximate expressions for Eqs. 5 and
6 so that, under optimal imaging conditions, the functional
dependence on TR and TI is removed from the right-hand side
of the equations. We start by examining the behavior of Eq. 5
shown in Fig. 2, where T1ayT1b is plotted as a function of T1b
for b 5 5 and several values of TR and kyN. Similar behavior
FIG. 1. Estimation of the lower limit to the contrast-to-noise-ratio
(b) that is visually obvious. Six capillary tubes containing various
aqueous GdHP-DO3A concentrations were imaged simultaneously.
The measured b, defined by Eq. 3, for the labeled pairs are 1.0, 4.8,
and 9.0, for A, B, and C, respectively. Average intensity differences are
easily discerned within pairs B and C, but not within A. We use a value
of b 5 5, or the approximate value for pair B, as the lower limit to b.
This image was acquired by using a two-dimensional Fourier transform
(2DFT) SE protocol with TEyTR 5 10y300 ms. The mean intensity for
each tube was measured over a region of interest (ROI) covering
approximately 2y3 the central area of a tube. The noise was obtained
from the mean voxel intensity (suppressed in this figure) over a
similarly sized ROI in a region outside the tubes.
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is observed for the case of IR (Eq. 6). Note that for a given kyN,
T1ayT1b passes through a maximum, which we label
ST1aT1bDmax [ G. [7]
This maximum corresponds to optimal imaging conditions
(Eq. 4) and occurs at a value T1b 5 (T1b)m. From Fig. 2, an
important observation is that G is independent of TR for a given
value of kyN. This observation is quite general and applies for
all values of kyN and TR of experimental interest. By using this
observation it can be readily shown that the ratio T9y(T1b)m is
also a function of kyN only. The goal then becomes to find
approximate functional forms of T9y(T1b)m that depend only
on kyN. These are substituted into Eqs. 5 and 6 to eliminate
the functional dependence on TR and T1b on the right-hand
side of these equations. We label the approximate functions for
T9y(T1b)m as f9(kyN) and F9(kyN) for SE and IR, respectively.
The functions f9 and F9 are found by numerically generating a
series of curves of T1ayT1b versus T1b for a large number of kyN
values and for arbitrarily fixed T9. Maxima for each of these
curves are found, and the corresponding (T1b)m are tabulated.
The resulting array of values for T9y(T1b)m, which is equal to
f9 or F9, is calculated and parametrically fit as a function of kyN.
The results are:
f9 5 0.920lnS kND 2 0.103F lnS kNDG
2
2 1.14 [8]
for SE, and
F9 5 0.539lnS kND 2 0.0618F lnS kNDG
2
2 0.223 [9]
for IR. We note that the above form of the fitting function is
not unique. The relations between Eqs. 5–9 are given by
G~k/N! 5 2f9F lnS2 5Nk 1 e2f9DG
21
[10]
for SE, and
G~k/N! 5 2F9F lnS2 52 Nk 1 e2F9DG
21
[11]
for IR.
The modification of T1 due to the presence of contrast agent
is described by
1
T1i
5
1
T01
1 Ri@M#i, [12]
where Ri and [M]i are the relaxivity and concentration of the
agent in region i 5 a, b. The ratio T1ayT1b is given by
T1a
T1b
5
1 1 T01Rb@M#b
1 1 T01Ra@M#a
. [13]
We substitute G for T1ayT1b in Eq. 13 and consider two limiting
cases in the TCM:
(i) [M]a Þ [M]b, Ra 5 Rb 5 R. This is the case of targeted
delivery. This includes, for example, agent delivery by strategic
uptake of the paramagnetic complex to cell surface receptors
or by microinjection techniques. From Eq. 13, the concentra-
tion in region a required to provide satisfactory contrast is
given by
@M#a 5
1 2 G
GT01R
1
@M#b
G
, [14]
where G is evaluated by using Eqs. 8 and 10 (SE) or 9 and 11
(IR). Normally [M]b 5 0 for the case of microinjection.
(ii) [M]a 5 [M]b 5 [M], Ra Þ Rb. This is the case where the
concentration of the agent is the same in both regions, but the
relaxivity differs in one of the regions due to biochemical
modification of the paramagnetic complex. From Eq. 13, we
obtain
@M# 5
1 2 G
T01~GRa 2 Rb!
, [15]
where the physically relevant concentrations are for GRa . Rb.
Experiment
To demonstrate the applicability of the TCM in a real exper-
imental system, we have performed a series of high-resolution
three-dimensional (3D) in vivo mMRI experiments on cleavage
and blastula stage Xenopus laevis embryos. Various concen-
trations of GdHP-DO3A were introduced into single blas-
tomeres by using calibrated microinjection techniques. The
TCM was used to predict the minimal agent concentration in
the labeled cells that would provide satisfactory image contrast
between labeled and unlabeled cells. Fig. 3 shows the calcu-
lated results from Eq. 14 with [M]a 5 [M], [M]b 5 0, and Ra 5
Rb 5 R. For a given value of kyN, images of cell populations
labeled with concentrations falling on or above the curve
should be easily distinguished from unlabeled cells, whereas
cells with concentrations significantly below the curve should
be indistinguishable.
Materials and Methods
To test the model predictions, we prepared a series of stage 4
(8-cell) Xenopus embryos, each with a single blastomere
injected with a known concentration and volume of GdHP-
DO3A. Two concentrations were used, and four embryos were
FIG. 2. The behavior of Eq. 5, where T1ayT1b is plotted as a
function of T1b for b 5 5 and several values of TR and kyN. Note that
for a given kyN, T1ayT1b passes through a maximum value, which we
label G. This maximum occurs at a value T1b 5 (T1b)m. An important
observation is that G is independent of TR for a given value of kyN.
Using this property, we obtain an approximate function for TRy(T1b)m
that depends only on kyN. This is substituted into Eq. 5 to eliminate
the functional dependence on TR and T1b on the right-hand side of this
equation. A similar procedure was used to obtain the relevant expres-
sions for IR.
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injected per concentration. Ascertaining the final concentra-
tion in the cell required an estimate of the dilution factor
obtained from knowledge of the agent volume delivered and
the volume of the targeted cell. The injection volume was
controlled by using a pulsed constant-pressure picoinjector
(PLI-100, Medical Systems, Greenvale, NY) that delivers a
reproducible volume of agent by means of a quartz micropi-
pette that impales the cell. The pressure and pulse duration of
the picoinjector were adjusted so that a 4-nanoliter (nl) bolus
was always delivered. The volume of the target blastomere was
estimated by measuring the diameter of the stage 4 animal cap
and assuming that a single blastomere represents 1y8 the
volume of a sphere whose diameter is equal to that of the
animal cap; typical values were about 125 nl. For the frogs used
in the imaging experiments, the final blastomere concentra-
tions were 5 and 200 mM, which differ by a factor of 40. The
uncertainty in these concentrations is estimated to be of order
of 614%; the primary source of uncertainty is in the estimation
of the blastomere volume, which varies between different
batches of eggs and is slightly overestimated when the mea-
surement procedure outlined above is used.
The agent concentrations do not change appreciably over
the time course of the imaging experiments (2–3 hr). At early
stages in frog development the total embryo volume remains
constant, and cell cleavage is not accompanied by cell growth.
As a result, the agent concentration within cells and their
progeny remains relatively constant throughout early devel-
opment. Furthermore, we observed no significant diffusion of
the agent across the cell membrane out of the injected cell and
its descendants.
After injection, the embryos were left at room temperature
in Ringer solution (13) for approximately an hour before
imaging to permit healing from the pipette wounding and to
allow the agent to uniformly diffuse throughout the blastomere
volume. After this period, four embryos of the same concen-
tration and one control (uninjected) embryo were placed in a
2.5-mm-diameter quartz tube in diluted Ringer solution
(0.13). The tube was placed in a laboratory-built radio fre-
quency solenoid microimaging probe, which was maintained at
a temperature of 15°C. At this temperature embryonic devel-
opment is normal but slowed. The embryos were imaged while
they developed through approximately stages 7 to 10. Images
were acquired by using a Bruker AMX500 (Bruker Instru-
ments, Billerica, MA) microimaging system with a wide-bore
(89-mm) 11.7-T magnet. A 3D SE pulse sequence was used to
acquire images with 256 3 64 3 64 image points, 1.28 3 0.32 3
0.32 cm field of view, and 50 mm isotropic resolution. The data
were zero-filled before Fourier transformation, yielding a final
isotropic resolution of 25 mm.
The acquisition parameters TE and TR were set to optimize
T1-weighted contrast between labeled and unlabeled cells
(regions a and b) for a fixed number of averages. TE was set to
the minimum value of 10.2 ms, which is limited by our imaging
system instrumentation. TR varied for each of the three
injection concentrations and was calculated by using Eq. 4. In
these calculations we set T1b 5 T01 5 1.3 6 0.2 s, which is the
measured T1 of unlabeled cells in the blastocoel roof; T1a was
calculated from Eq. 12 by using R 5 4.1 6 0.1 mM21zs21, which
is the relaxivity of GdHP-DO3A measured at 500 MHz and
15°C.
Results
Fig. 4 shows the in vivo images of representative Xenopus
embryos. The sets of contiguous panels labeled A and B are
25-mm-thick slices through separate embryos with blastomere
agent concentrations of 200 mM and 5 mM, respectively. A
control or uninjected embryo is shown in C. In A, labeled cells
(arrowheads) are clearly visible in the animal cap region and
appear hyperintense. In the lower concentration embryos (B),
no detectable contrast enhancement is observed compared
with the control.
From the results shown in Fig. 4, we calculated the param-
eter kyN for each image. First, the signal-to-noise ratio (ISE
b yN)
was measured for each image by standard methods (24). The
signal, ISE
b , was obtained from the mean intensity over a ROI
in unlabeled cells in the blastocoel roof. The statistical noise,
N, was measured from the mean image intensity over a ROI
containing no protons. In these experiments, ROIs contained
approximately 90 voxels. The measured ISE
b yN values for all
images ranged from 13 to 15. The kyN value for each image was
calculated by using Eq. 1 in the form of kyN 5 (ISE
b yN)y[1 2
exp(2TRyT1b)] in the limit of TE ,, TR, T2. Note that if the
images were acquired by using an IR pulse sequence, the
relevant equation would be kyN 5 (IIR
b yN)y[1 2 2exp(2TIy
T1b)]. In calculating kyN, we used the parameters ISE
b and T1b
for the uninjected cells, instead of the parameters for region a
(injected cells), although in principle either set should give
similar results. Normally, T1b is obtained by a direct T1
measurement using IR, for example. On the other hand, T1a is
calculated indirectly by using Eq. 12. Thus, under most cir-
cumstances, T1b is known to a higher accuracy than T1a.
For the Xenopus experiments, the relevant [M] and kyN
values are mapped onto Fig. 3. The image results are consistent
with the predictions of the TCM. The embryos with the largest
concentration, [M] 5 200 mM, are in a range where the labeled
blastomeres should easily be detected; this is observed in Fig.
4A. The embryos with [M] 5 5 mM fall below the curve, and
should be indistinguishable from unlabeled blastomeres; this is
also observed (Fig. 4B).
FIG. 3. Predictions using the TCM (solid line) for the minimal
agent concentration needed to give satisfactory image contrast for the
Xenopus microinjection imaging experiments. In this situation Eq. 14
applies, with [M]a 5 [M], [M]b 5 0, and Ra 5 Rb 5 R. For a given kyN,
cells labeled with concentrations falling on or above the curve are
easily distinguished from unlabeled cells; concentrations well below
the curve should not be detected. The TCM assumes a contrast-to-
noise ratio, b, equal to 5 (Fig. 1). Other values of b are also shown (b
5 2, dotted line; b 5 8, dashed line). The points at 5 and 200 mM
correspond to the agent concentrations in the labeled cells used in the
imaging experiments. These results are displayed in Fig. 4. In Fig. 3,
we emphasize that the data points only map the experimental condi-
tions onto the theoretical curve and are not used for fitting the model.
In calculating Fig. 3, we have used R 5 4.1 6 0.1 mM21zs21, which is
the relaxivity of GdHP-DO3A measured at 500 MHz, and T01 5 1.3 6
0.2 s, which is the T1 of unlabeled cells in the blastocoel roof. All
measurements were performed at 15°C.
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Discussion
We present a simple two-region model that can be used to
estimate the minimal MRI contrast agent concentration that
results in satisfactory contrast enhancement. Unlike previous
results, the model is designed to be applicable to a range of
imaging subjects and classes of contrast agents. The results of
the TCM are a set of equations that approximate the minimal
agent concentration when a finite concentration exists in one
or both regions, or when a functional agent is turned ‘‘on’’ in
one of the regions due to a modification in the agent’s
relaxivity. The TCM contains only a small number of param-
eters, which can realistically be estimated for a given system
and agent. These parameters include intrinsic properties of the
subject and agent, such as the ‘‘background’’ T1 of the subject,
the agent relaxivity, and the parameter kyN, which is closely
related to the image signal-to-noise ratio and is independent of
imaging protocol (SE or IR). The model is most useful in the
design of novel classes of contrast media, such as targeted and
functional agents.
Using an assay from developmental biology, we demonstrate
how the TCM can be applied to a real system of current
interest. In our assay, single blastomeres within Xenopus
embryos were labeled with known concentrations of GdHP-
DO3A, the model-specific parameters were evaluated, and it
was shown that the in vivo mMR images obtained were
consistent with predictions of the TCM.
In addition to contrast considerations, the model’s ability to
estimate the minimal agent concentration can also be impor-
tant for in vivo physiological characterizations, such as the
determination of agent toxicity, excretion pathways, and sta-
bility. Also, the model can be used to estimate the minimal
image signal-to-noise ratio required to obtain satisfactory
results for a given agent concentration; this ratio can influence
the choice of animal model or imaging parameters used for
testing the agent.
For realistic in vivo situations, the TCM is intended only to
provide reasonable expectations as to the minimal concentra-
tions. The accuracy of the TCM’s predictions are limited by the
extent to which model assumptions are valid and by uncer-
tainties in parameter values. The most stringent of the model’s
assumptions are the existence of equal spin densities in regions
a and b, and that T01
a 5 T01
b . (T2 variations between a and b can
also affect the model’s accuracy; however, this source of error
can be made small by minimizing TE.) In the Xenopus exper-
iments, the model’s assumptions are strictly met; however, this
is not always the case, especially when the two regions corre-
spond to different tissue types (25). If variation in spin density
and T01
i are small between the regions, the model can still
provide reasonable estimates. If higher-accuracy estimates are
desired in specific systems, extension of the TCM is straight-
forward. Starting with knowledge of the relative spin densities
andyor T01
i in a and b, and more general forms of Eqs. 1 and
2 (19–24), one can derive expressions analogous to Eqs. 5 and
6. Then, using the same numerical procedures outlined above,
one can obtain expressions similar to Eqs. 8–11.
The model parameters that require quantitative estimation
include [M]i, Ri, T01
i , and (IiyN). Measurement of the image
signal-to-noise ratio, IiyN, and the background longitudinal
relaxation, T01
i , is straightforward and is not discussed further.
On the other hand, estimating [M]i and Ri requires careful
experimental design. In most systems, [M]i is the most chal-
lenging to determine accurately. This was relatively simple in
the Xenopus experiments: [M]b 5 0 and [M]a was controlled by
calibrated microinjection. However, in systems where the
mechanism of agent delivery is more passive, such as through
selective uptake, determining [M]i may be more involved. For
example, [M]i could be determined by using a radioactive
analog of the agent. For low molecular weight hydrophilic
compounds, such as GdHP-DO3A, the values of Ri measured
in aqueous solutions are often good approximations to the
relaxivity in vivo (2). This situation has been demonstrated in
Gd-DTPA (26). For biochemically active agents, or agents
with binding interactions to proteins or membranes, Ri ideally
should be determined in vivo. This determination requires a
measurement of T1
i and an independent determination of [M]i;
FIG. 4. Slices through 3D in vivo mMR images of Xenopus embryos
labeled with calibrated microinjections of various concentrations of
GdHP-DO3A into single blastomeres. A single blastomeres in the
animal cap at stage 4 (8 cells) was injected, and the final agent
concentration in blastomere after dilution was estimated to be 200 mM
in A and 5 mM in B. A control or uninjected embryo is shown in C. The
embryos were imaged while they developed through approximately
stages 7 to 10. Regions common to all these embryos have been
indicated in the top panel of B: the blastocoel (bl), animal region (a),
vegetal region (v), and regions (R) containing the Ringer solution,
which is surrounding the embryos in the quartz tube. In A, the labeled
cells are clearly visible in the animal cap region (arrows) and appear
hyperintense. In B, no detectable contrast enhancement is observed
compared with the control (C) (matching the predictions of Fig. 3).
The vegetal region, which contains yolk, is darker in the image
presumably because of a small amount of T2-weighting. A 3D SE pulse
sequence was used to acquire images at 50-mm isotropic resolution.
The data were zero-filled before Fourier transformation, yielding a
final isotropic resolution of 25 mm. Single 25-mm slices are displayed
in each panel, and slices in contiguous panels are separated by 100 mm.
For all images, two scans per phase encoding step were averaged, and
TE 5 10.2 ms. The TR values were calculated by using Eq. 4 for each
concentration; TR values equal to 1.28 and 0.885 s were used for the
5 and 200 mM embryos, respectively. The images were acquired at
15°C.
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Ri can then be calculated by using Eq. 12. Several reviews (2,
27, 28) discuss additional issues concerning accurate quanti-
tation of [M]i and Ri in vivo.
As an example of the applicability of the TCM to functional
agents, consider the class of compounds described by Moats et
al. (17). In this family of agents, the relaxivity is increased in
response to local enzymatic activity. The mechanism for this
increase stems from a steric blocking of water access to the
inner coordination sphere of the Gd31 by using a galactopy-
ranose unit attached to the tetraazamacrocycle chelate. When
the agent is exposed to the enzyme b-galactosidase, the
galactopyranose ring is cleaved from the macrocycle, making
an inner coordination site of the Gd31 available for water
exchange; this availability effectively turns ‘‘on’’ the agent. For
the analysis of this agent, Eq. 15 is applicable. To estimate the
minimal agent concentration, we have used the in vitro relax-
ivities for the uncleaved and cleaved agent equal to 1.8
mM21zs21 and 2.4 mM21zs21, respectively (at 500 MHz),† and
we assume T01 equals the value for the unlabeled Xenopus
embryo (1.3 s). From Eq. 15 we see that the minimal concen-
tration is strongly dependent on the parameter kyN and
diverges at low kyN. For example, for a specific imaging system
and subject with a kyN value equal to 60, the minimal agent
concentration would be on the order of 1.4 mM.
Conclusions
Although MRI is a powerful tool for noninvasively mapping
biological structure and function, it is important to keep in
mind that the method has ubiquitous limitations in the avail-
able signal-to-noise ratio. This limitation is especially true as
the method is pushed to increasingly higher resolutions. A
consequence is that the ability to discriminate between tissues
on the basis of differences in T1 can be limited. Thus, when
exogenous contrast agents are utilized to enhance T1 differ-
ences, relatively large agent concentration or relaxivity differ-
ences must be delivered. Typically, for conventional agents,
concentrations in excess of '50 mM are required. When
developing new classes of contrast agents, it is important to
have an understanding of these concentration and relaxivity
requirements as a component of an overall design strategy. The
goal of this work is to provide this component.
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